Literature DB >> 5726793

Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones.

B B Brodie, E Costa, A Groppetti, C Matsumoto.   

Abstract

1. Small doses of tyramine (10 mug/kg intravenously) are taken up by rat heart, which can concentrate the amine 7.3-fold over the plasma level.2. Desipramine (DMI) blocks the uptake of small doses of tyramine by rat heart, but in doses of 20 mg/kg intraperitoneally, it does not affect the cardiac concentrations of tyramine following 20 mg/kg intramuscularly of the drug. The same dose of DMI prevents the depletion of noradrenaline (NA) elicited by intramuscular injection of tyramine 20 mg/kg.3. DMI prevents the depletion of heart NA elicited by (+)-amphetamine 5 mg/kg given intraperitoneally to demedullated rats and enhances the heart concentration of amphetamine.4. Liposoluble amphetamine enters sympathetic nerves by simple diffusion. It is suggested that DMI prevents the release of heart NA caused by this indirect sympathomimetic through an action within the adrenergic neurone.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5726793      PMCID: PMC1703529          DOI: 10.1111/j.1476-5381.1968.tb08494.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  THE SEPARATION OF CATECHOLAMINE STORAGE VESICLES FROM RAT HEART.

Authors:  I A MICHAELSON; K C RICHARDSON; S N SNYDER; E O TITUS
Journal:  Life Sci (1962)       Date:  1964-09

2.  BETA-HYDROXYLATION OF TYRAMINE IN VIVO.

Authors:  A CARLSSON; B WALDECK
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

3.  ANTAGONISM OF CERTAIN EFFECTS OF CATECHOLAMINE-DEPLETING AGENTS BY ANTIDEPRESSANT AND RELATED DRUGS.

Authors:  C A STONE; C C PORTER; J M STAVORSKI; C T LUDDEN; J A TOTARO
Journal:  J Pharmacol Exp Ther       Date:  1964-05       Impact factor: 4.030

4.  INTERACTION OF GUANETHIDINE WITH ADRENERGIC NEURONS.

Authors:  C C CHANG; E COSTA; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1965-03       Impact factor: 4.030

5.  Metabolism of norepinephrine-H3 released by tyramine and reserpine.

Authors:  I J KOPIN; E K GORDON
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

6.  The presence and distribution of tyramine in mammalian tissues.

Authors:  S SPECTOR; K MELMON; W LOVENBERG; A SJOERDSMA
Journal:  J Pharmacol Exp Ther       Date:  1963-05       Impact factor: 4.030

7.  The action of sympathomimetic amines in animals treated with reserpine.

Authors:  J H BURN; M J RAND
Journal:  J Physiol       Date:  1958-12-04       Impact factor: 5.182

8.  Kinetics of release of norepinephrine by tyramine.

Authors:  N H Neff; T N Tozer; W Hammer; B B Brodie
Journal:  Life Sci       Date:  1965-10       Impact factor: 5.037

9.  The effects of desmethylimipramine on uptake of dl-norepinephrine-7-H3 in the heart.

Authors:  E O Titus; N Matussek; H E Spiegel; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1966-06       Impact factor: 4.030

10.  SOME PHARMACOLOGICAL EFFECTS OF DESMETHYLIMIPRAMINE (DMI).

Authors:  E CUENCA; J A SALVA; F G VALDECASAS
Journal:  Int J Neuropharmacol       Date:  1964-05
View more
  8 in total

1.  Pupil responsiveness to tyramine in depressed patients treated with amitriptyline.

Authors:  E Szabadi; J Besson; C M Bradshaw
Journal:  Br J Clin Pharmacol       Date:  1975-08       Impact factor: 4.335

2.  The extraneuronal uptake and localization of noradrenaline in the cat spleen and the effect on this of some drugs, of cold and of denervation.

Authors:  J S Gillespie; D N Hamilton; J A Hosie
Journal:  J Physiol       Date:  1970-03       Impact factor: 5.182

3.  The effect of desipramine on neuronal responses to tyramine and noradrenaline in the cerebral cortex [proceedings].

Authors:  P Bevan; C M Bradshaw; R Y Pun; N T Slater; E Szabadi
Journal:  Br J Pharmacol       Date:  1978-03       Impact factor: 8.739

4.  A calcium-readmission response recorded from Nauphoeta salivary gland acinar cells.

Authors:  B L Ginsborg; C R House; M R Mitchell
Journal:  J Physiol       Date:  1980-07       Impact factor: 5.182

5.  Desipramine and some other antidepressant drugs decrease the major norepinephrine metabolite 3,4-dihydroxyphenylglycol-sulphate in the rat brain.

Authors:  M Nielsen; C Braestrup
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

6.  Protriptyline induced inhibition of the in vivo 3H-noradrenaline synthesis from 3H-L-dopa in the rat brain.

Authors:  M Nielsen; L Eplov; J Scheel-Krüger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  Comparison of the responses of single cortical neurones to tyramine and noradrenaline: effects of desipramine.

Authors:  P Bevan; C M Bradshaw; R Y Pun; N T Slater; E Szabadi
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

Review 8.  A reassessment of the safety profile of monoamine oxidase inhibitors: elucidating tired old tyramine myths.

Authors:  Peter Kenneth Gillman
Journal:  J Neural Transm (Vienna)       Date:  2018-09-25       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.